Compare Fiverr International Ltd (FVRR) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs Twist Bioscience Corp — how do they compare? Fiverr International Ltd trades at $8.63 (market cap $310.61M), while Twist Bioscience Corp trades at $152.84 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 32.5× Fiverr International Ltd's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and Twist Bioscience Corp for 27 Days on average.
| FVRR | TWST | |
|---|---|---|
Market Cap | $310.61M | $10.08B |
Volume | 381,459 | 4,229,037 |
Sector | Media | Health |
52-Week High | $23.60 | $205.00 |
52-Week Low | $8.47 | $25.45 |
Typical Hold Time | 62 Days | 27 Days |
Enterprise Value | $63.00M | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.50, up 0.35% on the day, but has faced recent pressure with two consecutive quarterly earnings misses. The stock shows a bearish technical signal, with moving averages indicating a downtrend, while fundamentals reveal modest revenue growth to $430.91M in 2025 and a net income margin of 4.86%. Recent news highlights AI disruption compressing demand for freelance services, contributing to a 15% stock slump post-Q2 results.
The outlook remains cautious; while valuation ratios like P/E of 10.49 and P/S of 0.74 appear attractive, risks from AI competition and lowered 2026 guidance weigh on sentiment. Analyst consensus is a 'Hold' with a $10.50 price target, suggesting limited upside amid operational headwinds. Investors should balance cheap valuations against execution risks in a shifting gig economy.
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
